IPO market rebounds to $2.54b in 2025, driven by ‘blockbuster’ REITs

Deloitte highlights two secondary listings, regulatory reforms.

Singapore led Southeast Asia’s initial public offering (IPO) market by proceeds, as 13 IPOs raised $2.54b (US$2.0b) with a market capitalisation of $7.87b (US$6.2b) in 2025, driven by a stronger pipeline of Mainboard listings and two notable secondary listings.

The city-state’s previous highest IPO record within five years was in 2021, when it accounted for about $1.52b (US$1.2b) in proceeds and $3.05b (US$2.4b) in market capitalisation from eight IPOs, a Deloitte report said.

The market had a downward trend in proceeds starting in 2022, when it raised $543.56m (US$428m) in that year, whilst $44.45m (US$35m) in 2023, and $43.18m (US$34m) in 2024.

Market capitalisation for 2022 crashed to $798.83m (US$629m), whilst it further dipped to $252.73m (US$199m) in 2023, and had a slight rebound to $347.98m (US$274m) in 2024.

The report also showed that there were 11 IPOs in 2022, six in 2023, and four in 2024.

The real estate sector led the industry breakdown, raising $1.905b (US$1.5b) from four IPOs, which is 76% of Singapore’s total funds raised.

The sector is followed by the Life Sciences & Health Care sector with $508.00m (US$400m) from one IPO, and Technology, Media & Telecommunication with $60.96m (US$48m) from one IPO.

Other sectors include Consumers with $34.29m (US$27m) from five IPOs, Energy & Resources with $13.97m (US$11m) from one IPO, and Industrial Products with $6.35m (US$5m) from one IPO.

The Deloitte report also cited two “blockbuster” listings—namely NTT DC REIT and Centurion Accommodation REIT—which raised more than $635.00m (US$500m) each, accounting for 70% of Singapore’s total funds raised.

It also noted two secondary listings—China Medical Systems and Avepoint, Inc.—whilst cross-border listings include those from NASDAQ and Hong Kong Exchange Listings.

The Monetary Authority of Singapore (MAS) and Singapore Exchange (SGX) issued reforms for a disclosure-based regime to enhance market attractiveness.

SGX also lowered the profit test threshold for Mainboard admission from $30m to $10m.

MAS also plans to enhance the appeal of dual listings in Singapore and on NASDAQ by providing a seamless pathway for companies seeking such.

The city-state’s gross domestic product is also poised for 1.4% growth, according to the report.

US$1 = SG$1.27

Follow the link for more news on

Deloitte

A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia